Medicine recalls
|
| |
| The United States: Shaman Botanicals, LLC issues voluntary nationwide recall of Alkaloids Chewable Tablets—White Vein due to undeclared concentration of 7-Hydroxymitragynine (7-OH) |
| |
The US Food and Drug Administration (FDA) announces that Shaman Botanicals, LLC is voluntarily recalling one lot (Lot B# AAW.501.3) of Alkaloids Chewable Tablets—White Vein to the consumer level. Recent testing showed that the Alkaloids Chewable Tablets—White Vein product contains 7-Hydroxymitragynine (7-OH) in an amount more than the declared value of 7.5 mg/tablet.
Use of the Alkaloids Chewable Tablets—White Vein product could result in consumers ingesting a higher dose than intended, which could result in adverse health effects. Shaman Botanicals, LLC has not received any reports of adverse events related to this lot of Alkaloids Chewable Tablets—White Vein.
The product is packaged in a 2-count bag with UPC Code 810057763724, in a 20-count bag with UPC Code 810057763830 and in a 30-count bottle with UPC Code 810057763779. The affected Alkaloids Chewable Tablets—White Vein lot has the following lot number: Lot B# AAW.501.3 (all expiration dates). The Alkaloids Chewable Tablets—White Vein product was distributed nationwide to wholesalers, retailers, and consumers via online sales.
Please refer to the following website in FDA for details:
http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/shaman-botanicals-llc-issues-voluntary-nationwide-recall-alkaloids-chewable-tablets-white-vein-due
In Hong Kong, there is no registered pharmaceutical product containing 7-Hydroxymitragynine (7-OH).
Ends/Friday, Feb 20, 2026
Issued at HKT 17:30
|
| |
